NORTHROP GRUMMAN CORP•Financial Summary•AI-Powered Insights

NORTHROP GRUMMAN CORP 2026 Q3
Earnings Overview & AI Insights

Detailed performance report for NORTHROP GRUMMAN CORP covering Q3 2026. Gain clarity on earnings, revenue trends, and AI-enhanced strategic analysis.

NORTHROP GRUMMAN CORP (2026 Q3)

Earnings Performance

No Performance Data

Summary of Financial Performance: Northrop Grumman delivered a strong third quarter with sales of $11.1 billion, up 7% year over year, and segment operating income up 5% with a 12.1% margin. EPS rose 3% to $7.89. Backlog reached a record $110 billion, up 20%, supported by bookings above $16 billion and a 1.5x book-to-bill. Free cash flow was strong at $1.8 billion, up over 40% year over year. Management raised full-year 2026 EPS and segment operating income guidance while maintaining sales and free cash flow outlooks.

Company Outlook & Strategy: Management remains confident in durable long-term growth, citing strong program execution, portfolio breadth, and disciplined capital deployment. 2026 guidance was raised for segment operating income, margins, and EPS. For 2027, the company expects sales growth of 5% to 7%, with operating income growing faster than sales and margins expanding. Longer term, growth is expected to accelerate further as B-21 production ramps, Sentinel progresses, national security space expands, and international sales grow. Capital spending remains elevated to support future production capacity.

Key Industry Trends: The company highlighted rising global defense demand, an ongoing multiyear upswing in allied defense budgets, and increasing need for scalable capabilities in contested environments. Management emphasized demand for munitions, missile defense, sensors, crewed and uncrewed aircraft, counter-UAS systems, and space-based communications. The threat environment and evolving adversary capabilities continue to shape customer priorities.

Operational Highlights: Major program progress included Sentinel milestones, including first full vertical assembly of an inert missile and Air Force approval for first-flight design maturity. In space, Northrop launched and deployed its first 21 satellites for the Tranche 1 transport layer, with nearly 50 of 150 satellites expected to deploy in the next six months. The company also advanced autonomous flight testing with Talon Blue, introduced the FORTITUDE microelectronics chip, and expanded manufacturing and engineering capacity in four states, adding over 1 million square feet and more than 2,000 jobs. A $1.4 billion Virginia-class submarine award added backlog.

Challenges & Risks: Management noted uncertainty related to the U.S. continuing resolution and pending appropriations, though it said the company is relatively insulated due to its budget mix. Execution risk remains tied to ramping major programs like B-21, Sentinel, and space deployments, as well as higher capital intensity in coming years. The company also acknowledged the need to manage cost, production throughput, and timing of revenue on certain contracts.

Key Analyst Questions & Responses: The main Q&A question focused on what could drive the low versus high end of 2027 growth and whether some 2028 acceleration could shift into 2027. Management’s response emphasized that 2027 growth is supported by strong program execution, higher production volumes, and continued demand, but specific upside will depend on ramp timing across B-21, Sentinel, space, and munitions programs. They indicated that 2028-style acceleration could potentially be pulled forward if program milestones and production ramps progress faster than expected.

Earnings Call Transcript

Access the official earnings call transcript for NORTHROP-GRUMMAN-CORP 2026 Q3. It provides valuable insights into management commentary, performance drivers, and forward-looking guidance directly from the company.